Related Experiment Video
Updated: Jul 29, 2026
07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
4.0K
American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines
Heather M Alger1, Christine Rutan1, Joseph H Williams1
1Quality, Outcomes Research and Analytics Department, American Heart Association, Dallas, TX (H.M.A., C.R., J.H.W., J.G.W., M.B., J.L.H.).
Circulation. Cardiovascular Quality and Outcomes
|June 18, 2020
Summary
The American Heart Association rapidly created the COVID-19 Cardiovascular Disease Registry to aid research. This registry collects patient data to improve care and understanding of COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic created an urgent need for rapid scientific advancement.
- The American Heart Association (AHA) established the COVID-19 Cardiovascular Disease (CVD) Registry powered by Get With The Guidelines.
- The registry began collecting clinical records in under four weeks from its April 2020 announcement.
Purpose of the Study:
- To expedite scientific advancement through shared learning, quality improvement, and research.
- To provide a resource for the medical and research community.
- To understand the impact of COVID-19 on cardiovascular disease.
Main Methods:
- Hospitals enroll consecutive hospitalized patients with active COVID-19.
- Patient-level data, including mortality, ICU, and ventilator days, are abstracted from electronic medical records.
- Data are used for onsite quality improvement and benchmarking.
Main Results:
- Over 130 sites enrolled within nine weeks.
- More than 4000 patient records were abstracted into the national dataset.
- The registry serves as a valuable data resource for medical research.
Conclusions:
- The AHA COVID-19 CVD Registry will enhance understanding of COVID-19's effects on cardiovascular disease.
- Findings will inform best practices for evaluating and managing patients with COVID-19.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...